PI-LAB-2025-181

Orforglipron, Independent Lab Report

Orforglipron 24mg · Meridian Health Direct

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97.7% met the stated ≥98% claim. Content measured 100.8% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.7%

Label claimed ≥98%

Content accuracy
100.8%

24.18mg measured against 24mg claimed

Test recency
Current cycle

Published 12 months ago

Specimen PI-LAB-2025-181 Tested by Cornerstone Analytical 8 samples tested from this company Purity & Testing score 97/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97.7% Within analytical tolerance
Identity (MS) Orforglipron Confirmed Matches label
Content 24 mg 24.18 mg Within 5% of label

Methodology & chain of custody

RP-HPLC purity with electrospray ionisation mass confirmation.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Cornerstone Analytical. See our full testing methodology.

Lot / batch
A4397-25
Purchased
Analysed
Published
Laboratory
Cornerstone Analytical
Test type
Full panel (purity, identity, content, endotoxin)

Original laboratory report: PI-LAB-2025-181-report.pdf (document delivery arrives with the production storage backend)

More Tests, Meridian Health Direct

Semaglutide (Oral)
Purity 97.5% Verified
Orforglipron
Purity 98.1% Verified
Cagrilintide
Purity 97.0% Verified

More Tests, Orforglipron

Orforglipron Cardinal Metabolic Clinic
Purity 98.6% Verified
Orforglipron Meridian Health Direct
Purity 98.1% Verified
Orforglipron Verity Research Chemicals
Purity 98.3% Verified